π Definition
Hodgkin’s Disease is a type of lymphoma characterized by the presence of Reed-Sternberg cells. It primarily affects lymphatic tissue and has a high cure rate when diagnosed early.
π§ Anatomy & Physiology: Lymphatic System
- Lymph nodes: Filter lymph fluid and house immune cells
- Spleen: Filters blood, stores WBCs, and fights infection
- Thymus: Site of T-cell maturation
- Lymph: Clear fluid that circulates immune cells
β οΈ Etiology: Causes & Risk Factors
Potential causes:
- Epstein-Barr Virus (EBV) infection
- Genetic predisposition
- Immunosuppression (e.g., HIV/AIDS)
Risk factors:
- Young adults (15β35 years) or >55 years
- Family history
- Male sex slightly more common
π©Ί Symptomatology
- Painless lymphadenopathy (cervical, supraclavicular)
- Fever, night sweats, weight loss (B symptoms)
- Fatigue and pruritus
- Alcohol-induced lymph node pain (rare)
- Splenomegaly/hepatomegaly in advanced cases
π Pathophysiology (Simplified)
- Mutation of B lymphocytes in lymph nodes
- Formation of multinucleated Reed-Sternberg cells
- Clonal expansion in lymphatic tissue
- Disruption of immune response
- Spread in orderly fashion from node to node
π§ͺ Medical Management
π¬ Labs & Diagnostics
- Lymph node biopsy β confirms Reed-Sternberg cells
- CT/PET scan β staging and spread
- CBC β anemia, leukocytosis
- ESR, LDH β markers of inflammation/tumor burden
π Medications
- ABVD regimen: Adriamycin, Bleomycin, Vinblastine, Dacarbazine
- Targeted therapy: Brentuximab vedotin
π οΈ Treatments
- Chemotherapy β primary treatment
- Radiation therapy β for localized disease
- Stem cell transplant β for relapsed/refractory cases
π§ββοΈ Nursing Management: 5 Key Interventions
- Monitor for infection and neutropenia
- Manage chemotherapy-related side effects
- Educate on signs of recurrence
- Support nutritional status and energy conservation
- Provide psychosocial support for body image and anxiety
π©Ή Priority Nursing Diagnoses
- Risk for infection
- Fatigue related to disease process
- Imbalanced nutrition: Less than body requirements
- Disturbed body image
- Anxiety
π Prognosis
- Stage IβII: 85β90% 5-year survival
- Stage III: 70β80%
- Stage IV: ~60%
Reminder: Early diagnosis and adherence to treatment greatly improve outcomes.